Physician profile
Jorge Con
NPI 1972715704
$15,601.88
in general payments reported to CMS, 2019-2025
7 companies · $1,452 in 2025
The $1,452 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $74.08 · 2021: $80.29 · 2022: $122 · 2023: $13K · 2024: $54.16 · 2025: $1,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Travel and Lodging: $2,827 · Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $11,520.00 |
| Travel and Lodging | $2,827.48 |
| Food and Beverage | $602.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,270.63 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $1,452.21 | 2025 | Progrip |
| Allergan, INC. | $651.63 | 2019-2022 | |
| Abbvie INC. | $132.62 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Kerecis Limited | $40.63 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Teleflex LLC | $34.16 | 2024 | Arrow |
| Csl Behring | $20.00 | 2024 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Con listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.